UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Drug metabolism and disposition, 2017-06, Vol.45 (6), p.657-665

2017

Volltextzugriff (PDF)

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Drug metabolism and disposition, 2021-08, Vol.49 (8), p.619-628

2021

Volltextzugriff (PDF)

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Drug metabolism and disposition, 2014-12, Vol.42 (12), p.2023-2032

2014

Volltextzugriff (PDF)

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

Clinical pharmacokinetics, 2024-02, Vol.63 (2), p.241-253

2024

Volltextzugriff (PDF)

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

Xenobiotica, 2016-11, Vol.46 (11), p.986-1000

2016

Volltextzugriff (PDF)

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.477-484

2018

Volltextzugriff (PDF)

A pregnancy physiologically based pharmacokinetic (p‐PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

British journal of clinical pharmacology, 2012-11, Vol.74 (5), p.873-885

2012

Volltextzugriff (PDF)

Drug Disposition in Obesity: Toward Evidence-Based Dosing

Annual review of pharmacology and toxicology, 2015-01, Vol.55 (1), p.149-167

2015

Volltextzugriff (PDF)

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Xenobiotica, 2011-12, Vol.41 (12), p.1063-1075

2011

Volltextzugriff (PDF)

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Pharmaceutical research, 2012-10, Vol.29 (10), p.2860-2873

2012

Volltextzugriff (PDF)

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

The Journal of pharmacology and experimental therapeutics, 2015-01, Vol.352 (1), p.110-118

2015

Volltextzugriff (PDF)

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Drug metabolism and disposition, 2013-06, Vol.41 (6), p.1179-1186

2013

Volltextzugriff (PDF)

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Volltextzugriff (PDF)

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity

Clinical pharmacology and therapeutics, 2022-08, Vol.112 (2), p.391-403

2022

Volltextzugriff (PDF)

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

Drug metabolism and disposition, 2016-01, Vol.44 (1), p.28-39

2016

Volltextzugriff (PDF)

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.703-709

2023

Volltextzugriff (PDF)

Pharmacogenetics of artemether‐lumefantrine influence on nevirapine disposition: Clinically significant drug–drug interaction?

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.540-550

2019

Volltextzugriff (PDF)

Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol

Clinical pharmacology and therapeutics, 2018-09, Vol.104 (3), p.525-533

2018

Volltextzugriff (PDF)

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Volltextzugriff (PDF)

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.386-399

2008

Volltextzugriff (PDF)

Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition

Clinical pharmacology and therapeutics, 2019-01, Vol.105 (1), p.142-152

2019

Volltextzugriff (PDF)

Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans

Acta pharmacologica Sinica, 2022-02, Vol.43 (2), p.494-503

2022

Volltextzugriff (PDF)

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Xenobiotica, 2014-11, Vol.44 (11), p.996-1008

2014

Volltextzugriff (PDF)

Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline

Xenobiotica, 2017-08, Vol.47 (8), p.682-696

2017

Volltextzugriff (PDF)

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.139-147

2018

Volltextzugriff (PDF)

1 – 25 von 10.634

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Pharmacology

ThemaAdult

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.413)
Mit Volltextzugriff
(8.091)

Publikationsform

Artikel
(10.634)

Sprache

Englisch
(10.630)
Japanisch
(1.905)
Russisch
(9)
Französisch
(5)
Deutsch
(5)
Norwegisch
(4)
Chinesisch
(2)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10.634)
Science & Technology
(10.634)
Humans
(10.632)
Male
(9.141)
Female
(7.111)
Middle Aged
(5.859)
Biological And Medical Sciences
(5.375)
Medical Sciences
(5.338)
Pharmacology. Drug Treatments
(5.025)
Aged
(3.187)
Pharmacokinetics
(2.716)
Young Adult
(2.477)
Adolescent
(2.300)
Administration, Oral
(2.021)
Area Under Curve
(1.681)
Half-Life
(1.582)
Dose-Response Relationship, Drug
(1.407)
Drug Interactions
(1.402)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(10.627)
Lippincott E Journal Collection
(6.583)
Wiley-Blackwell Journals
(5.194)
IngentaConnect
(3.900)
EZB Electronic Journals Library
(3.601)
Wiley Online Library
(3.389)
Single Journals
(2.946)
IngentaConnect Journals
(2.626)
Springer journals
(2.249)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.465)
Nexis Uni
(738)
Elsevier ScienceDirect Journals Complete
(500)
Taylor & Francis
(330)
Taylor & Francis Journals Auto-Holdings Collection
(310)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(232)
Taylor & Francis Journals Complete
(213)
SAGE Complete
(180)
Oxford journals
(178)
Nature Journals
(171)
Oxford Journals 2020 Medicine
(121)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition

A pregnancy physiologically based pharmacokinetic (p‐PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

Drug Disposition in Obesity: Toward Evidence-Based Dosing

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Pharmacogenetics of artemether‐lumefantrine influence on nevirapine disposition: Clinically significant drug–drug interaction?

Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition

Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Aktive Filter

Suchergebnisse filtern